News Quantified

VIVO – vivopower plc - ordinary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response Program

VivoPower Launches Lease Bidding after Receiving Strong Interest from AI Operators for 41.5MW Norway Data Center

VivoPower Becomes EBITDA Profitable: $31 Million Revenue, $10 Million EBITDA From Completion of Norway Data Center Acquisition

VivoPower PLC Ordinary Shares (VIVO) was upgraded by Wall Street Zen

VivoPower PLC Ordinary Shares (VIVO) is now covered by Weiss Ratings. They set a "sell (d-)" rating on the stock.

Top News Gainers

1/27 Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak 20.8%

3/17 Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 16.8%

3/13 Form 4 MERIDIAN BIOSCIENCE INC For: Mar 12 Filed by: Kenny John P. 15.1%

4/2 MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH 10.6%

4/14 Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests 8.5%

7/30 Q3/2019 6/30/2019 EPS 0.160 ZacksConsensus 0.100 ActVsEst 0.060 - Beat 7.2%

3/16 FDA clears Meridian Bioscience's new Curian analyzer and Curian HpSA assay [Seeking Alpha] 6.0%

4/16 Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020 5.4%

10/15 Form 4 MERIDIAN BIOSCIENCE INC For: Oct 11 Filed by: Kenny John P. 5.0%

2/7 Meridian Bioscience Inc (VIVO) Q1 2020 Earnings Call Transcript [The Motley Fool] 4.9%

Top News Decliners

11/7 Q4/2019 9/30/2019 EPS 0.130 ZacksConsensus 0.090 ActVsEst 0.040 - Beat -16.2%

2/7 Q1/2020 12/31/2019 EPS 0.100 ZacksConsensus 0.060 ActVsEst 0.040 - Beat -15.7%

1/27 Meridian Bioscience joins coronavirus rally, up 28% [Seeking Alpha] -10.9%

1/27 Form 8-K MERIDIAN BIOSCIENCE INC For: Jan 27 -10.8%

2/6 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -5.2%

8/14 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.1%

9/25 Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.5%

11/8 Meridian Bioscience Inc (VIVO) Q4 2019 Earnings Call Transcript [The Motley Fool] -4.4%

2/26 Form 4 MERIDIAN BIOSCIENCE INC For: Feb 25 Filed by: McIlwraith John -4.2%

3/10 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -4.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day